Discover how to buy shares of Oncolys BioPharma (2OB.F), Tutorial in english

oncolys biopharma

Oncolys BioPharma Inc. is engaged in the research, development, manufacture, sale, import and export of viruses, drugs and oncolytic drugs, and tumor diagnostic agents in Japan, the rest of Asia and the United States. The company operates in two segments, pharmaceutical business and diagnostic business. Its product pipeline includes Telomelsin (OBP-301), an adenovirus oncolytic that is in Phase II clinical trial for the treatment of gastric/gastroesophageal junction, head and neck, and esophageal cancers; and in the phase I clinical trial for the treatment of hepatocellular carcinoma. The company’s product pipeline also includes OBP-702, a telomerase-specific ontolytic adenovirus, which is in a preclinical trial for the treatment of solid tumors; OBP-2001, which is in preclinical testing for the treatment of SARS-COV-2 virus infection; OBP-601 (CENSAVUDINE), a nucleotide reverse transcriptase inhibitor that has completed a Phase IIB clinical trial for the treatment of HIV infection; and OBP-801, a histone deacetylase inhibitor, which is in phase I clinical trial for the treatment of solid tumors, as well as in preclinical trial for ophthalmic use. In addition, it develops telomesca (OBP-401 and OBP-1101), a cancer detection drug, to detect live circulating tumor cells in the blood of cancer patients. In addition, the company provides diagnostic drugs, devices and inspection services. It has several licensing agreements with Okayama University, Osaka University,

Discover how to buy shares of Oncolys BioPharma (2OB.F), Tutorial in Spanish

Are you interested in buying Oncolys BioPharma (2OB.F) shares in Frankfurt in Spain and through a regulated broker? Would you like to be able to monetize your monthly benefits and make profits on the stock market? In this tutorial I am going to show you how easy it is to register with Degiro , a reliable German investment bank with low commissions, and how you can get Oncolys BioPharma Inc. (2OB.F) (2OB.F) shares quickly and easily. .

What we will do is easy to follow :

  • First of all, we will create a degiro account, a broker platform where we will be able to buy shares of the company Oncolys BioPharma Inc. (2OB.F) (2OB.F).
  • In 2nd place we will enter funds to be able to make the 1st investment.
  • When we have the funds we will proceed to locate the company Oncolys BioPharma using its Ticker, which is 2OB.F.
  • To finish, we must adjust the number of shares we want to buy, the value and the type of order.

It is possible that the summary has been somewhat simple for you, therefore I am going to summarize the step by step with images.

How to open an account with Degiro

First of all, we will register an account with DEGIRO using the following link :

buy shares of Oncolys BioPharma Inc. (2OB.F)

It will ask us for an email, a name and a password to access, and then we must follow the link that they have sent us by email address.

Then Degiro will ask us for some important information in order to accept our identification document . We must have at hand the passport number, ID or driving license, the mobile and the number of the bank account that we are going to apply to carry out our first deposit in IBAN format. If you do not perceive what method this format is, you can check this simple usage tutorial that we have prepared .

stock Oncolys BioPharma

Once our account is approved, we will have to pay money from the Enter/Extract option. We can proceed to make a bank transfer that will take 1-2 days, or make the deposit instantly with Sofort, a truly secure and reliable payment gateway.

deposit money into Oncolys BioPharma account

How to buy Oncolys BioPharma (2OB.F) shares through Degiro

When we have the money we will be able to get our 1st share. You can use the Place Order button that is located at the top right or use the Degiro search engine and paste the ticker. In the next image you will see that I have used the Amazon Ticker but in your case you have to place (2OB.F), the Oncolys BioPharma ticker. As we are talking about an action, we will see that the related results are listed and there we will look to find Oncolys BioPharma. What is key is that the ticker, the name of the action and the market in which it is listed coincide. Amazon is listed on NASDAQ (NDQ) and in your case Oncolys BioPharma Inc. (2OB.F) is listed in Frankfurt. This step is very essential so do not make a mistake.

American stock market opens what hours Oncolys BioPharma

At the moment of placing the order we must be attentive to what I am going to explain to you . We will be able to place a limit or market order. Imagine that you plan to buy a share of Oncolys BioPharma, but its price is currently higher. With a limit order, we will place the value at which we calculate to make the operation and until there are no shares for sale at that price, the acquisition of the share will not be executed. With a market order, DeGiro will buy the number of shares that we have added to the current selling price, which is going to be closely related to the current trading price.

Closed-Market Limit Order Oncolys BioPharma Inc. (2OB.F)

In both cases it is essential that you look at the type of alignment: permanent or daily . For example, in Spain, the stock market is from morning until 1 in the afternoon, and in the US it corresponds to the afternoon schedule in Spain. If an order is permanent, it will be kept until the moment it gets executed, but if you opt for the “of the day” option, when the session ends, if it had not been carried out, it will be deleted from your Activity file – Orders in process .

I would love that this simple post has helped you to buy shares in Oncolys BioPharma. Thank you very much.

  Company information
  • Oncolys BioPharma Inc. (2OB.F) Address: Toranomon Towers Office
    4-1-28 Toranomon Minato-ku
    Tokyo 105-0001
    81 3 5472 1578
    – Website:
  • Ticker: 2OB.F
  • Industry: Unknown
  • Industry: Unknown
  • Number of employees: 36
  • Listed market: Frankfurt

key executives

Name Title Salary exercised Year of birth
Mr Yasuo Urata Director, Pres Representative Director N/A N/A 1955

Recent events of :

We have no recent events for this company.